Please login to the form below

biologic

This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.

Novartis agrees to help produce Roche’s repurposed COVID-19 drug

Novartis is fully committed to collaborating with Roche in offering our proven biologics production capabilities,” said Steffen Lang, head of Novartis technical operations and member of the Novartis executive committee.

Latest news

FDA approves new self-injection administration for Xolair

The FDA has approved the biologics licence application (BLA) for Xolair(omalizumab) prefilled syringe for self-injection across all approved indications in the US.
CanSinoBIO considers booster jab for COVID-19 vaccine

The efficacy of Chinese biotech company CanSino Biologics's (CanSinoBio) single-dose COVID-19 vaccine could decrease over time, according to the company’s chief scientific officer Zhu Tao.
BMS and bluebird bio gain FDA approval for multiple myeloma therapy

Following this, BMS and bluebird re-filed the biologics licence application, saying that the new application provided further details about the chemistry, manufacturing and control (CMC) module of the submission to
Lilly reports positive data from its phase 3 ulcerative colitis trial

Mirikizumab also reduced symptoms in patients who had previously not responded to or stopped responding to biologic and/or Janus Kinase (JAK) inhibitor drugs.
AZ, Amgen’s tezepelumab reduces asthma exacerbations in broad patient population

In a statement, AZ said that tezepelumab is the first and only biologic medicine to consistently and significantly reduce AAER in a broad population of severe asthma patients, irrespective of baseline ... The unprecedented results from the NAVIGATOR

More from news
Approximately 21 fully matching, plus 603 partially matching documents found.

Latest Intelligence

Keeping up with the developing regulatory requirements for gene and cell therapies

Other safety and manufacturing events such as three patient deaths in the high-dose arm of the Audentes’ ASPIRO trial and an FDA refusal to review the biologics licence application for
Growing evidence supports the important role of biosimilars in healthcare

In 2019, four of the top five prescription expenditures in the US were biologics and accounted for approximately $46 billion in expenditures. ... An estimated 1.2 million US patients could gain access to biologics by 2025 as the result of increasing
The US celebrates five years of biosimilars on the market – a look to the past, present and future

In comparison to many small-molecule medicines, biologics are often challenging to develop and costly to produce. ... patient access to more affordable, high-quality, and potentially life- changing biologic treatments.
Exploring the potential of eosinophils

Peter Howarth (pictured above), Global Clinical Scientific Lead for Biologics at GSK looks at the emerging science behind eosinophils and how it is helping to guide the company’s research and ... decisions. The eosinophils test is now well-established
BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches

in the manufacturing of complex biologic therapies, Amgen is leveraging this expertise to meet this growing need.

More from intelligence
Approximately 5 fully matching, plus 87 partially matching documents found.

Latest appointments

Ex-BMS exec jumps to Gilead to lead research group

That included the expansion of the company’s biologics and biomarker functions, as well as the addition of inflammation, oncology and immunology discovery groups.
New hires at Crescendo, Healx and Galecto

The latest movers in pharma. Crescendo. Crescendo Biologics has appointed Kenji Hashimoto as its new chief medical officer, who joins Crescendo with over 15 years of experience in oncology and ... Kenji has considerable immuno-oncology expertise and an
New hires at FibroGen, Saniona and Turbine

Tuna currently serves as chief scientific officer at Adaptate Biotherapeutics, and has over 15 years of experience in biologics drug discovery and development.
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Bahija has more than 25 years of international leadership experience within the pharmaceutical industry, and joins Immunocore from AstraZeneca, where she has served as President of MedImmune, its global biologics research ... A champion for science and
BMS appoints new commercial leader, Davies joins Eisai and more

Commenting on her appointment, Schuermans said: “Sobi has unique capabilities, a heritage in biologics manufacturing, development and supply, and a very exciting future within the rare disease space.

More from appointments
Approximately 8 fully matching, plus 48 partially matching documents found.

Latest from PMHub

Integrated NHS finances: what do they mean for High Cost Drugs?

So, those with High Cost biologics are going to have to think carefully about their value proposition.
Living with psoriasis: a patient perspective

million[i]) received a biologic therapy in the UK in 2012.
Covid-19: how is it affecting prescribing patterns?

because as generic biologics get approved, use of branded biologics goes down and the arthritis pathway becomes cheaper to run. ... Yet, Gilenya aside, we found the medications trending upward were orally administered, which demonstrates a market
Are biobetters a market access opportunity?

Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen. ... Biobetters are enhanced versions of originator biologics, which potentially offer added value to
Innovative pricing and contracting options

3. For new entrants in the biologics space, adopting net pricing options is crucial since some US payers are volume sensitive and may prefer an older competitor drug that is clinically

More from PMHub
Approximately 7 fully matching, plus 41 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Head of Strategic Planning, Healthcare Advertising/ Brand comms,...: Six figure salary

Publications Director: Competitive Salary

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Account Manager: Competitive Salary

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

Medical Editor: Competitive Salary

Senior Account Manager/ Account Director: Competitive Salary Offered

Editorial Traffic Manager, Medical Communications Agency, London...: up to £45K

Senior & Principal Medical Writers Medical Communications - ...: Salary TBC

Account Manager - Creative Healthcare Communications - South Wes...: Excellent Remuneration

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Account Executive: Competitive Salary

Account Management: Competitive Salary Offered

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Associate Account Director: Competitive Salary

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Senior & Principal Medical Writer: Competitive Salary Offered

Medical Writers (All levels) Editorial / Scientific Leads & ...: Highly Competitive Remuneration packages

Group Account Director, Healthcare Advertising/ Brand comms, Lon...: 8 month contract up to £90K

Senior Medical Writer: Competitive Salary

PMHub

Add my company

Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?: Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials: Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity: Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....

Email:
Password:

Please login to the form below

biologic

COVID-19 Updates and Daily News

Featured jobs

Quick links